You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 7, 2025

Drug Price Trends for NDC 62332-0741


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 62332-0741

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

62332-0741 Market Analysis and Financial Projection

Market Analysis and Price Projections for Drug NDC: 62332-0741

Understanding the National Drug Code (NDC)

To analyze the market and project prices for a specific drug, it is crucial to understand the National Drug Code (NDC) system. The NDC is an 11-digit code assigned to each drug product, including prescription and over-the-counter drugs, and is used to identify the product, its manufacturer, and its packaging[1].

Identifying the Drug

The NDC 62332-0741 corresponds to a specific drug product. However, without the exact name of the drug, we must rely on general trends and data to make informed projections.

Market Trends in Prescription Drugs

Price Increases and Volatility

Prescription drug prices have shown significant volatility and increases over recent years. From January 2022 to January 2023, the average price increase for single-source drugs was 7.4%, while multi-source drugs saw an average increase of 26.0%[2].

Seasonal Patterns

Price changes for prescription drugs tend to cluster around specific times of the year. The largest number of price increases typically occur in January and July, indicating that these periods are critical for monitoring price changes[2].

Geographic Price Disparities

The United States has significantly higher prescription drug prices compared to other regions. In 2022, prices in the U.S. were 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world[4].

Factors Influencing Drug Prices

Competition from Generics and Biosimilars

Competition from generic drugs and biosimilars is a significant factor affecting drug prices. As patents expire, generic and biosimilar versions of drugs enter the market, often reducing prices. However, for drugs with unique formulations or those still under patent, prices may remain high[3].

Regulatory and Market Dynamics

Regulatory changes, such as those related to drug approval and reimbursement, can significantly impact drug prices. Additionally, market dynamics, including demand and supply chain factors, play a crucial role in determining prices[3].

Technological and Therapeutic Advances

Advances in genomics, biomarkers, and personalized medicine are transforming the life sciences industry. These innovations can lead to more precise and effective treatments but may also result in higher initial costs due to the complexity and novelty of these therapies[3].

Price Projections for NDC 62332-0741

Given the general trends and factors influencing drug prices:

Short-Term Projections

  • January and July Increases: Expect potential price increases in these months, aligning with the seasonal patterns observed in the industry.
  • Average Price Changes: If the drug is a single-source product, a price increase around 7-10% could be anticipated, while multi-source drugs might see higher percentage increases[2].

Long-Term Projections

  • Competition Impact: If the drug faces competition from generics or biosimilars in the near future, prices could decrease significantly.
  • Regulatory and Market Changes: Any changes in regulatory policies or market conditions could impact the price. For example, if the drug is subject to price controls or if there are changes in reimbursement policies, prices could be affected[3][4].

Example Scenario

If the drug NDC 62332-0741 is a single-source product with no immediate generic competition, here is a possible scenario:

  • Current Price: Assume the current price is $100 per unit.
  • Short-Term Increase: A 7-10% increase in January could raise the price to $107-$110 per unit.
  • Long-Term Outlook: If the drug remains under patent and without significant competition, prices might continue to rise, potentially by 5-10% annually, reaching $120-$140 per unit over the next few years.

Key Takeaways

  • Seasonal Price Increases: Monitor January and July for potential price changes.
  • Competition Impact: Generic and biosimilar competition can significantly reduce prices.
  • Regulatory and Market Dynamics: Changes in regulations and market conditions can impact prices.
  • Technological Advances: New therapies and formulations may lead to higher initial costs but improved patient outcomes.

FAQs

  1. What is the National Drug Code (NDC) and how is it used?

    • The NDC is an 11-digit code that identifies a drug product, its manufacturer, and its packaging. It is used by the FDA to track and regulate drug products[1].
  2. Why do prescription drug prices tend to increase more in January and July?

    • These periods are when the largest number of price increases typically occur, possibly due to annual budget reviews and strategic pricing adjustments by manufacturers[2].
  3. How do generic and biosimilar drugs affect the prices of branded drugs?

    • Generic and biosimilar drugs often reduce prices significantly by introducing competition into the market, leading to lower prices for consumers[3].
  4. What role do regulatory changes play in drug pricing?

    • Regulatory changes, such as those related to drug approval and reimbursement policies, can significantly impact drug prices by affecting the cost structure and market dynamics[3].
  5. How do technological advances in healthcare impact drug prices?

    • Technological advances, such as personalized medicine and new therapeutic formulations, can lead to higher initial costs but also improve patient outcomes and potentially reduce long-term healthcare costs[3].

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Changes in the List Prices of Prescription Drugs, 2017-2023 - ASPE
  3. 2025 life sciences outlook - Deloitte Insights
  4. International Market Size and Prices - ASPE
  5. Label: ARIPIPRAZOLE tablet - DailyMed

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.